We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Osteoporosis Assay from Astra Biotech GmbH
Product News

New Osteoporosis Assay from Astra Biotech GmbH

New Osteoporosis Assay from Astra Biotech GmbH
Product News

New Osteoporosis Assay from Astra Biotech GmbH


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "New Osteoporosis Assay from Astra Biotech GmbH"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Astra Biotech GmbH have now developed the new Osteoporosis Kit diagnostic test kit using RT-PCR for the detection of polymorphisms in the COLIA1 and VDR genes to improve the identification of defects which result in abnormalities in bone matrix mineralization.

The Company claims that the Osteoporosis assay is an assay which tests both polymorphisms and is more sensitive and convenient than alternative assays. The new kit includes all the necessary primers, enzymes, positive controls and buffers sufficient for 100 assays.

The Osteoporosis assay is produced following strict quality control procedures and using only certified high purity reagents, being in addition IVD compliant and therefore suitable for clinical applications. If the risk of osteoporosis is identified at an early stage then suitable treatment regimes may be introduced to minimize the risk of bone deterioration in line with Astra Biotech GmbH’s philosophy that prevention is better than a cure.
Advertisement